Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry AnalysisAmit Kulkarni, Narjust Florez, Clara Hwang et al.|Clinical Lung Cancer|2024Cited by 3
Phase 1/2 study of spevatamig (PT886) in combination with gemcitabine plus nab-paclitaxel (GnP) in frontline (1L) treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC).Anwaar Saeed, Harshabad Singh, Michael J. Overman et al.|Journal of Clinical Oncology|2026Cited by 2